Literature DB >> 20656351

Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections.

Stephen J Kim1, Hassanain S Toma, Narinder K Midha, Edward F Cherney, Franco M Recchia, Terrence J Doherty.   

Abstract

PURPOSE: To determine the baseline antibiotic susceptibility patterns of conjunctival and nasopharyngeal flora isolated from patients undergoing intravitreal (IVT) injections for choroidal neovascularization (CNV).
DESIGN: Prospective, observational study. PARTICIPANTS: Forty-eight eyes of 24 patients undergoing unilateral IVT injections for CNV.
METHODS: Bilateral conjunctival and unilateral nasopharyngeal cultures on the treatment side were taken before application of any topical medications. MAIN OUTCOME MEASURES: Bacterial isolates were identified and tested for antibiotic susceptibility to 16 different antibiotics using the Kirby-Bauer disc diffusion technique.
RESULTS: A total of 57 bacterial isolates were obtained from the conjunctiva of 48 eyes. Coagulase-negative staphylococci (CNS) accounted for 37 of the 57 isolates (65%). The most common CNS organisms were Staphylococcus epidermidis and Staphylococcus lugdunensis accounting for 73% and 11% of CNS isolates, respectively. More than half of S. epidermidis isolates demonstrated some level of resistance to ofloxacin and levofloxacin, and 33% and 37% of isolates showed some level of resistance against gatifloxacin and moxifloxacin, respectively. Some 60% and 30% of CNS isolates were resistant to ≥ 3 and ≥ 5 antibiotics, respectively. Among the 24 nasopharyngeal cultures, 8 (33%) grew Staphylococcus aureus, and 1 of the 8 isolates (13%) was resistant to all penicillin, cephalosporin, macrolide, and fluoroquinolone antibiotics tested.
CONCLUSIONS: Our results demonstrate subtantial levels of resistance to third- and fourth-generation fluoroquinolones and multiresistance among ocular CNS isolated from patients undergoing IVT injections for CNV.
Copyright © 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20656351     DOI: 10.1016/j.ophtha.2010.03.034

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

1.  Antibiotic prophylaxis for preventing endophthalmitis after intravitreal injection: a systematic review.

Authors:  Francesca Menchini; Giacomo Toneatto; Alba Miele; Simone Donati; Paolo Lanzetta; Gianni Virgili
Journal:  Eye (Lond)       Date:  2018-06-11       Impact factor: 3.775

2.  Effects of moxifloxacin exposure on the conjunctival flora and antibiotic resistance profile following repeated intravitreal injections.

Authors:  Mustafa Ataş; Burhan Başkan; Ayşe Ozköse; Fatma Mutlu Sarıgüzel; Süleyman Demircan; Emine Pangal
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

3.  The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection.

Authors:  Philip Storey; Michael Dollin; Nadim Rayess; John Pitcher; Sahitya Reddy; James Vander; Jason Hsu; Sunir Garg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-05       Impact factor: 3.117

4.  The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.

Authors:  Jose Benitez-Del-Castillo; Yves Verboven; David Stroman; Laurent Kodjikian
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

5.  Emerging 8-methoxyfluoroquinolone resistance among methicillin-susceptible Staphylococcus epidermidis isolates recovered from patients with endophthalmitis.

Authors:  Paulo J M Bispo; Eduardo C Alfonso; Harry W Flynn; Darlene Miller
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

6.  Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis.

Authors:  Kathryn J Ray; Lalitha Prajna; Muthiah Srinivasan; Manoharan Geetha; Rajarathinam Karpagam; David Glidden; Catherine E Oldenburg; Catherine Q Sun; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal:  JAMA Ophthalmol       Date:  2013-03       Impact factor: 7.389

Review 7.  Antibioprophylaxis in Prevention of Endophthalmitis in Intravitreal Injection: A Systematic Review and Meta-Analysis.

Authors:  Cédric Benoist d'Azy; Bruno Pereira; Geraldine Naughton; Frédéric Chiambaretta; Frédéric Dutheil
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

Review 8.  Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review.

Authors:  Rohan Merani; Alex P Hunyor
Journal:  Int J Retina Vitreous       Date:  2015-07-21

9.  Intravitreal injections of anti-VEGF agents and antibiotic prophylaxis for endophthalmitis: A systematic review and meta-analysis.

Authors:  Manuel F Bande; Raquel Mansilla; María P Pata; Maribel Fernández; María José Blanco-Teijeiro; Antonio Piñeiro; Francisco Gómez-Ulla
Journal:  Sci Rep       Date:  2017-12-22       Impact factor: 4.379

10.  The effect of topical ocular moxifloxacin on conjunctival and nasal mucosal flora.

Authors:  Ali Riza Cenk Celebi; Ozlem Onerci Celebi
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.